Inventor · disambiguated record
Keith Jendza
Also filed as: JENDZA KEITH
23 granted patents·4 pending applications·271 citations·filing 2008–2024
95Inventor score
Top patents by PatentIndex Score
27 records- 0198US7879896B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Feb 1, 2011·53 cites·30 claims
- 0298US7777077B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Aug 17, 2010·34 cites·34 claims
- 0397US8013005B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Sep 6, 2011·42 cites·22 claims
- 0496US9056874B2Complement pathway modulators and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2013·Granted Jun 16, 2015·95 cites·29 claims
- 0592US8158659B2Dual-acting imidazole antihypertensive agentsALLEGRETTI PAUL·Filed 2010·Granted Apr 17, 2012·11 cites·32 claims
- 0690US11485742B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Nov 1, 2022·2 cites·22 claims
- 0789US11548865B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2020·Granted Jan 10, 2023·2 cites·29 claims
- 0886US8344013B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 1, 2013·4 cites·7 claims
- 0986US8236846B2Dual-acting antihypertensive agentsALLEGRETTI PAUL·Filed 2011·Granted Aug 7, 2012·5 cites·24 claims
- 1084US8569351B2Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2012·Granted Oct 29, 2013·3 cites·3 claims
- 1183US8895755B2Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2013·Granted Nov 25, 2014·3 cites·1 claims
- 1283US8349875B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 8, 2013·3 cites·24 claims
- 1381US9676728B22-benzyl-benzimidazole complement factor B inhibitors and uses thereofADAMS CHRISTOPHER·Filed 2014·Granted Jun 13, 2017·6 cites·12 claims
- 1480US9475806B2Complement factor B inhibitors and uses there ofADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Oct 25, 2016·6 cites·14 claims
- 1578US8143298B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2010·Granted Mar 27, 2012·1 cites·6 claims
- 1677US2024140959A12-azaspiro[3.4]octane derivatives as m4 agonistsNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1776US9150514B2Dual-acting antihypertensive agentsALLEGRETTI PAUL·Filed 2014·Granted Oct 6, 2015·1 cites·26 claims
- 1874US12129246B1Hydroquinazoline derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2024·Granted Oct 29, 2024·0 cites·30 claims
- 1974US11820778B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Nov 21, 2023·0 cites·30 claims
- 2070US12122761B22-azaspiro[3.4]octane derivatives as M4 agonistsNOVARTIS AG·Filed 2022·Granted Oct 22, 2024·0 cites·25 claims
- 2169US8637676B2Dual-acting benzoimidazole antihypertensive agentsALLEGRETTI PAUL·Filed 2008·Granted Jan 28, 2014·0 cites·33 claims
- 2264US8735625B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2013·Granted May 27, 2014·0 cites·1 claims
- 2360US9198899B2Dual-acting benzoimidazole antihypertensive agentsALLEGRETTI PAUL·Filed 2013·Granted Dec 1, 2015·0 cites·33 claims
- 2458US8394846B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2012·Granted Mar 12, 2013·0 cites·1 claims
- 2556US2024208953A1"Cyclopenta[c]pyrrol Negative Allosteric Modulators of NR2B"NOVARTIS AG·Filed 2022·Application pending·0 cites
- 2641US2016145247A1Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereofBELANGER DAVID B·Filed 2014·Application pending·0 cites
- 2740US2015250767A1Complement pathway modulators and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Keith Jendza files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →